Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mucormycosis – An opportunistic infection in the aged immunocompromised individual: A reason for concern in COVID-19
Vivek P. Chavda, Vasso Apostolopoulos
Maturitas (2021) Vol. 154, pp. 58-61
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

SARS‐CoV‐2 variants and vulnerability at the global level
Vivek P. Chavda, Aayushi Patel, Darsh D. Vaghasiya
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2986-3005
Open Access | Times Cited: 108
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 72
A Global Picture: Therapeutic Perspectives for COVID-19
Vivek P. Chavda, Carron Kapadia, Shailvi Soni, et al.
Immunotherapy (2022) Vol. 14, Iss. 5, pp. 351-371
Open Access | Times Cited: 71
Therapeutics for COVID-19 and post COVID-19 complications: An update
Debdoot Basu, Vivek P. Chavda, Anita A. Mehta
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100086-100086
Open Access | Times Cited: 68
Unveiling the promise: Exosomes as game‐changers in anti‐infective therapy
Vivek P. Chavda, Guanghong Luo, Rajashri Bezbaruah, et al.
Exploration (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 19
DNA vaccines for SARS-CoV-2: toward third-generation vaccination era
Vivek P. Chavda, Radhika Pandya, Vasso Apostolopoulos
Expert Review of Vaccines (2021) Vol. 20, Iss. 12, pp. 1549-1560
Open Access | Times Cited: 95
Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena
Vivek P. Chavda, Md. Mer Mosharraf Hossain, Jayesh Beladiya, et al.
Biologics (2021) Vol. 1, Iss. 3, pp. 337-356
Open Access | Times Cited: 77
Herbal Remedies, Nutraceuticals, and Dietary Supplements for COVID-19 Management: An Update
Vivek P. Chavda, Aayushi Patel, Disha R. Vihol, et al.
Clinical Complementary Medicine and Pharmacology (2022) Vol. 2, Iss. 1, pp. 100021-100021
Open Access | Times Cited: 62
Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery
Muhammad Iqbal Nasiri, Lalitkumar K. Vora, Juhaina M. Abu Ershaid, et al.
Drug Delivery and Translational Research (2021) Vol. 12, Iss. 4, pp. 881-896
Open Access | Times Cited: 55
Therapeutic monoclonal antibodies for COVID-19 management: an update
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 51
Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants
Vivek P. Chavda, Disha Valu, Palak K. Parikh, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 374-374
Open Access | Times Cited: 29
COVID-19 and vaccination: myths vs science
Vivek P. Chavda, Yangmin Chen, Jayant Dave, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 11, pp. 1603-1620
Closed Access | Times Cited: 34
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
Zoufang Huang, Vivek P. Chavda, Lalitkumar K. Vora, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Pseudoscience and fraudulent products for COVID-19 management
Vivek P. Chavda, Shreya S. Sonak, Nafesa K. Munshi, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 42, pp. 62887-62912
Open Access | Times Cited: 28
Post-COVID-19 Fungal Infection in the Aged Population
Vivek P. Chavda, Toshika Mishra, Sathvika Kamaraj, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 555-555
Open Access | Times Cited: 12
Ayurvedic and Other Herbal Remedies for Dengue: An Update
Vivek P. Chavda, Anup Kumar, Rittwika Banerjee, et al.
Clinical Complementary Medicine and Pharmacology (2022) Vol. 2, Iss. 3, pp. 100024-100024
Open Access | Times Cited: 16
COVID-19 Case Fatality Rate and Factors Contributing to Mortality in Ethiopia: A Systematic Review of Current Evidence
Derara Girma, Hiwot Dejene, Leta Adugna, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 3491-3501
Open Access | Times Cited: 11
Co-Infection Associated with SARS-CoV-2 and Their Management
Vivek P. Chavda, Aayushi Patel, Anjali Pandya, et al.
Future Science OA (2022) Vol. 8, Iss. 9
Open Access | Times Cited: 10
AI, ML and Other Bioinformatics Tools for Preclinical and Clinical Development of Drug Products
Avinash Khadela, Sagar Popat, Jinal Ajabiya, et al.
(2023), pp. 255-284
Closed Access | Times Cited: 5
Exenterate or Not: A Simple Proposed Management Algorithm for Mucormycosis During the Era of COVID-19 in a Tertiary Eye Care Center in Egypt
Reham Refaat Shabana, Mohamed Ashraf Eldesouky, Hazem A. Elbedewy
Clinical ophthalmology (2022) Vol. Volume 16, pp. 1933-1940
Open Access | Times Cited: 8
Galangin for COVID-19 and Mucormycosis co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and Mucormycosis
Md Imran Hasan, Md. Arju Hossain, Md Habibur Rahman, et al.
Network Modeling Analysis in Health Informatics and Bioinformatics (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Rhino-Orbital Mucormycosis After COVID-19 Recovery: A Case Report
Ana Filipa Moleiro, Ana Maria Cunha, Rodrigo Vilares-Morgado, et al.
International Medical Case Reports Journal (2022) Vol. Volume 15, pp. 579-586
Open Access | Times Cited: 6
Nitric Oxide and its Derivatives Containing Nasal Spray and Inhalation Therapy for the Treatment of COVID-19
Vivek P. Chavda, Lalitkumar K. Vora, Rajeev K. Singla, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 46, pp. 3658-3670
Closed Access | Times Cited: 6
Amphotericin B- and Levofloxacin-Loaded Chitosan Films for Potential Use in Antimicrobial Wound Dressings: Analytical Method Development and Its Application
Ke Peng, Mingshan Li, Achmad Himawan, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2497-2497
Open Access | Times Cited: 6
Data Analytics and Data Visualization for the Pharmaceutical Industry
Shalin Parikh, Ravi Patel, Dignesh Khunt, et al.
(2023), pp. 55-76
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top